Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease
The Global Biobank Meta-analysis Initiative (GBMI) unites 24 biobanks, including CanPath and its regional cohorts, with data from over 2.2 million people, to power global genetic discovery. By integrating diverse genetic info, GBMI improves disease risk prediction, advances personalized medicine, and boosts discoveries. CanPath contributes Canadian data, adding diversity and impact! Together, they’ve harmonized data, improved data on Read more about Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease[…]